SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-099576
Filing Date
2016-05-06
Accepted
2016-05-06 16:02:44
Documents
49
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v437905_10q.htm 10-Q 329917
2 EXHIBIT 31.01 v437905_ex31-01.htm EX-31.01 9800
3 EXHIBIT 31.02 v437905_ex31-02.htm EX-31.02 9586
4 EXHIBIT 32.01 v437905_ex32-01.htm EX-32.01 4844
  Complete submission text file 0001144204-16-099576.txt   2785988

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tnxp-20160331.xml EX-101.INS 490141
6 XBRL TAXONOMY EXTENSION SCHEMA tnxp-20160331.xsd EX-101.SCH 28689
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tnxp-20160331_cal.xml EX-101.CAL 25287
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tnxp-20160331_def.xml EX-101.DEF 214283
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tnxp-20160331_lab.xml EX-101.LAB 255599
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tnxp-20160331_pre.xml EX-101.PRE 240788
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 161627902
SIC: 2834 Pharmaceutical Preparations